Skip to content

Early Remote Rehabilitation to Improve Health of the Elderly After Cardiac Surgery. (RECARD Trial)

Early REmote Rehabilitation to Improve Health of the Elderly After CARDiac Surgery. (RECARD Trial). A Bi-center, Prospective, Randomized, Open-label, Blinded Evaluation (PROBE) Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06370611
Acronym
RECARD
Enrollment
118
Registered
2024-04-17
Start date
2024-05-01
Completion date
2026-08-15
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Rehabilitation

Keywords

Cardiac Surgery, Mobile Health, Elderly, Exercise, Randomised Controlled Trial

Brief summary

An increasing number of older patients undergo heart surgery. Despite seemingly successful outcomes, these vulnerable patients may face prolonged decreased functional capacity, reduced self-efficacy, and impaired quality of life after discharge. Early engagement in physical activity and education plays a key role in health and well-being after heart surgery The goal of this clinical trial is to evaluate the effectiveness of an app-based exercise program and weekly calls from a physiotherapist in the early stages after open heart surgery. Eligible patients will be randomly assigned to either a control group receiving standard care or an intervention group, which will be introduced to an individually tailored exercise program as an addition to standard care. Follow-up is planned with an out-patient visit six weeks after discharge and a telephone interview six months post-surgery. All participants will undergo assessments at enrollment and during follow-up. Physical performance will be evaluated through physical tests. General well-being, quality of life, self-reported physical activity, and cost-effectiveness of the intervention will be assessed through questionnaires. Muscle health will be examined through blood sampling, CT scans, and muscle biopsies. The primary endpoint is the 30-second Chair Stand Test serving as a measurement of physical function.

Detailed description

Hypotheses: Primary: Early mobile health intervention at home supplemented by weekly calls from a physiotherapist after cardiac surgery improves functional outcomes, exercise tolerance, and quality of life in older patients. Secondary: * Cardiac surgery increases the prevalence and extent of sarcopenia in the elderly which can be mitigated by early mobile health intervention * Sarcopenia on Chest Computed Tomography (CCT) is strongly correlated to functional outcome and quality of life following cardiac surgery * Early mobile health intervention is feasible and cost-effective Design: This is a bi-center, prospective, randomized controlled, parallel, two-arm, open-label, blinded evaluation (PROBE) trial with a superiority design. The study population will consist of a representative group (n=120) of older patients scheduled for open heart surgery who fulfill the requirements according to inclusion and exclusion criteria. The patients will be recruited from 2 cardiac surgery centers in northern and central Denmark. Patients are stratified after center and subsequently randomly allocated (1:1) to receive mobile health intervention as an adjunct to standard care (Intervention Group), or standard care alone (Control group) for 6 weeks after discharge. Follow-up is planned with an outpatient visit 6 weeks after discharge, and a telephone interview 6 months after surgery. Patients in the intervention group receive a 6-week home-based CR using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The patients are equipped with a case including an ICURA -sensor with a charger, an illustrative quick guide, and a contact telephone number. According to the patient's preference, the app is either installed on their own mobile phone or provided on a separate mobile device. The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, text message communication with patients, and a password-protected webpage for physiotherapists to customize training programs and track patient activity. A few days after discharge, patients in the intervention group will receive the first call from the physiotherapist, to ensure, that the patient is using the ICURA app actively. The patients will receive two calls per week for the first two weeks and as required the following four weeks.

Interventions

DEVICEEarly mobile health intervention supplemented by weekly calls from a physiotherapist

Six-week home-based rehabilitation program using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, and a password-protected webpage for physiotherapists to customize training programs and track patient activity. The patients will receive two calls from a physiotherapist per week for the first two weeks and as required the following four weeks.

Sponsors

Ivy susanne Modrau, MD
Lead SponsorOTHER
Aalborg University Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Allocation cannot be concealed from the participants, care providers or investigator. Outcome assessors will be blinded regarding allocation.

Intervention model description

Bi-center, prospective, randomized, controlled, parallel (1:1), two-arm, open-label, blinded evaluation (PROBE) trial

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of signed and dated informed consent form * Scheduled first-time heart surgery through median sternotomy * Male or female, aged ≥ 65 years (The age criterion implies the exclusion of women of childbearing potential)

Exclusion criteria

* Medical conditions requiring referral to specialized rehabilitation (e.g., severe heart or lung failure, need for blood pressure monitoring during exercise) * Emergent procedure * Anticipated inability to perform intervention, study assessment procedures, or follow-up * Participation in any other interventional clinical that may interfere with the outcome measures

Design outcomes

Primary

MeasureTime frameDescription
Change (Δ) 30-second chair stand test (30CST) baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgeryRecording of the number of stands a person can complete from a chair without arms in 30 seconds

Secondary

MeasureTime frameDescription
Change (Δ) in 10-meter Walk Test (10MWT) baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeMeasurement of walking speed in meters per second over a 10-meter distance
Difference in 6-minute Walk Test (6MWT) between groups at 6-week FU6 weeks (+/- 4 days) after dischargeMeasurement of walking distance in 6 minutes.
Change (Δ) in WHO-5-score baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery5-item World Health Organization Well-Being Index (WHO-5), questionnaire assessing subjective well-being
Change (Δ) in ASS-2-score baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgeryAnxiety Symptom Scale-2 (ASS-2), questionnaire assessing anxiety
Change (Δ) in MDI-2-score baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgeryMajor Depression Inventory-2 (MDI-2), questionnaire assessing depression
Change (Δ) in Self-reported Physical Activity baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgeryQuestionnaire assessing self-reported physical activity
Change (Δ) in EuroQol-score baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgeryEuroQol-5-Dimension-5-Level Questionnaire (EQ-5D-5L), questionnaire assessing health-related quality of life
Change in skeletal muscle mass baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeBody composition analysis with artificial-intelligence-assisted medical image analysis (CT scan) (DAFS©, Veronoi Health Analytics, Vancouver, Canada) to assess quantity and quality of skeletal muscle.
Cost-effectiveness analysis1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgeryQuestionnaire assessing the cost-effectiveness of the intervention in comparison to usual care
Changes in markers of musculoskeletal health through blood samples baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeMarkers of muscle health: Myoglobin, Creatine Kinase (CK)
Changes in markers of inflammation through blood samples baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeInflammatory markers: White Cell Count (WCC), Platelet Count, Mean Platelet Volume (MPV), Immature Platelet Fraction (IPF), High-Sensitive C-Reactive Protein (hs-CRP)
Changes in markers of nutrition through blood samples baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeNutritional markers: Hemoglobin, Glycated Hemoglobin (HbA1c), fasting glucose, Albumin, Triglycerides, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), Vitamin B12, Folate, 25-OH-Vitamin D2+D3
Changes in markers of liver function through blood samples baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeLiver Function Markers: Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT)
Changes in markers of kidney function through blood samples baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeKidney Function Markers: Creatinine, estimated Glomerular Filtration Rate (eGFR)
Changes in markers of hormone levels through blood samples baseline vs. 6-week FU1-7 days prior to surgery and 6 weeks (+/- 4 days) after dischargeHormonal Markers: Cortisol, Free/Total Testosterone, Sex Hormone Binding Globulin (SHBG), Insulin-like Growth Factor-1 (IGF-1)
Assessment of muscle quality through obtainment of biopsies of the pectoralis major muscle at the surgeryAt surgeryAnalysis of pectoralis major muscle biopsies

Countries

Denmark

Contacts

STUDY_CHAIRIvy S. Modrau, MD, dr.med.

Aarhus University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026